Dr Andrea Nemeth, Consultant Clinical Geneticist and Honorary Senior Lecturer at Oxford’s Churchill Hospital and the University of Oxford, is part of a team that is currently testing two next-generation sequencing platforms – the Roche 454 and Illumina systems – for use in a hospital setting.
They’re benchmarking these two next-generation platforms against gold standard Sanger sequencing techniques.
The research is funded by AtaxiaUK, the Oxford Biomedical Research Centre, the National Institute of Health Research and DeNDRoN.
For more information click here.